Burundi vs Chad: Incidence of tuberculosis, low uncertainty bound
Burundi
122 per 100,000 people
in 2011
Chad
125 per 100,000 people
in 2011
Burundi rank
32nd
Chad rank
31st
Incidence of tuberculosis, low uncertainty bound over time
- Burundi
- Chad
How they compare
Chad currently reports 125 per 100,000 people against 122 per 100,000 people in Burundi, a difference of 3 per 100,000 people.
The two have swapped places 1 time across 22 shared years of data; in 1990 it was Burundi ahead.
Burundi ranks 32nd and Chad ranks 31st of 53 countries.
Across the 3 decades both report, Burundi averaged higher in 2 and Chad in 1.
Head to head by decade
| Decade | Burundi | Chad | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 243.4 per 100,000 people | 102 per 100,000 people | 141.4 per 100,000 people | Burundi |
| 2000s | 185 per 100,000 people | 125.3 per 100,000 people | 59.7 per 100,000 people | Burundi |
| 2010s | 124.5 per 100,000 people | 125 per 100,000 people | 0.5 per 100,000 people | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, low uncertainty bound, Burundi or Chad?
- Chad, at 125 per 100,000 people against 122 per 100,000 people in Burundi as of 2011.
- What is the difference in incidence of tuberculosis, low uncertainty bound between Burundi and Chad?
- 3 per 100,000 people, with Chad ahead.
- How many years of comparable data are there for Burundi and Chad?
- 22 years are reported by both, from 1990 to 2011.
- How do Burundi and Chad rank globally for incidence of tuberculosis, low uncertainty bound?
- Burundi ranks 32nd and Chad ranks 31st of 53 countries.
- Where does this data come from?
- World Health Organization, Global Tuberculosis Control Report, published as Incidence of tuberculosis, low uncertainty bound (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new pulmonary, smear positive, and extra-pulmonary tuberculosis cases.